Asia-Pacific CRO George Clinical has topped up its cancer services and boosted its U.S. presence after acquiring Memphis, Tennessee-based Vector Oncology'…

After raising $31 million just last year, California-based clinical research company Science 37 has now served up a Series C round worth $29 million.

Texas-based Moleculin Biotech penned a deal with Theradex Systems to help it run early-stage trials for its candidate annamycin in acute myeloid leukemia.

Accelovance has launched a program focused on advancing early-phase oncology R&D efforts, which the company says haven’t received enough support from the…

Takeda is nearing the final stages of a joint venture with PRA Health Sciences, the product of an expansion of their clinical development partnership in Japan…

Embattled biotech Karyopharm is looking to move past its recent trial setbacks, penning an expansion to its original 2014 partnership on machine-learning tech…

Drug discovery firm Nimbus Therapeutics has reached a multiyear partnership with Charles River Laboratories.

A bipartisan bill that plans to allow a tax credit for expenses of contracted research—often done by CROs—has been introduced in the House of Representatives.

Axim Biotechnologies, which explores medical uses of cannabis, has decided to continue contracting Ora to manage its drug R&D activities and clinical…

The European Medicines Agency wants to suspend around 300 marketed generic meds and applications due to its concerns.

R&D